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Abstract 
Background: Limited previous research has assessed the psychosocial burden and productivity impact of caring for 
a child with peanut allergy and factors associated with burden. The objective of this research was to explore caregiver 
burden in terms of psychosocial and productivity impact of caring for a child with peanut allergy, the influence of 
caregiver and child gender on caregiver burden, and factors predicting caregiver burden in peanut allergy.
Methods: A cross-sectional survey of caregivers of children with peanut allergy was conducted in the United 
Kingdom, and included sociodemographic and clinical questions, EQ-5D, Hospital Anxiety and Depression Scale, Food 
Allergy Quality of Life-Parental Burden, Food Allergy Independent Measure, and productivity questions.
Results: One hundred caregivers (55% female) of children with peanut allergy (aged 4–15 years) completed the 
survey. Male and female caregivers reported mean levels of anxiety significantly higher than United Kingdom 
population norms. Caregivers of children with severe peanut allergy reported significant impacts on their careers 
and health-related quality of life. Neither caregiver nor child gender impacted burden, indicating that male and 
female caregivers are equally anxious and suffer the same level of negative career, productivity, and health-related 
quality-of-life impact due to their child’s peanut allergy. Caregivers’ perceived risk of outcomes related to their child’s 
peanut allergy (e.g., death or severe reaction) as measured by the Food Allergy Independent Measure independently 
predicted burden.
Conclusions: Caregivers of children with peanut allergy in the United Kingdom experience health-related quality-of-
life, psychosocial, and productivity burden; this study demonstrates the high levels of anxiety reported by both male 
and female caregivers.
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Background
Peanut allergy affects between 0.6% and 1% of the adult 
population and between 1% and 3% of children in the 
developed world [1, 2], and studies suggest the prevalence 
is increasing in the United Kingdom (UK) [3]. There 
is currently no approved treatment for peanut allergy 
outside of the United States; therefore, management 
requires strict avoidance of peanuts and emergency 
treatment in the case of accidental ingestion.
Previous research has identified several areas of 
caregivers’ health-related quality of life (HRQL) that 
are affected by having a child with food allergy. Parents 
of children with food allergies report significantly 
greater emotional impact, impact on parental time, and 
limitations in usual family activities than do population 
norms in the United States [4]. Similarly, parents of 
children with food allergies report significantly greater 
emotional impact [5] and effect on social relationships 
[6] than do parents of children with no allergic diseases. 
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An older study that used a convenience sample in 
comparison with rheumatological disease, a condition 
that is very dissimilar to allergy, found impairment of 
family relations reported by parents of children with 
peanut allergy [7]. In addition, parent-reported food 
allergy is associated with caregiver stress, although 
parents of children who have undergone an oral food 
challenge report significantly less stress [8]. Even with 
suspected food allergy prior to clinical diagnosis, the 
level of anxiety in parents was significantly higher than in 
those who had just been diagnosed with a chronic illness 
[9].
Many factors have been associated with increased 
caregiver burden for those with food allergies. Food 
allergy characteristics, including type and number of 
food allergens, type and severity of symptoms, previous 
anaphylactic reactions, adrenaline autoinjector use, and 
oral food challenge history have been found to influence 
parental burden [8, 10–14]. In addition, factors such as 
lower caregiver income and education, child’s age and 
age at most severe reaction, parental self-efficacy for food 
allergy management, and negativity experienced in social 
relationships have also been shown to influence caregiver 
burden [11, 12, 14, 15].
Limited research has explored whether caregiver 
gender influences the amount of burden experienced by 
caregivers of children with food allergies; some evidence 
suggests gender does make a difference. One study found 
that mothers reported significantly lower HRQL than 
fathers but greater empowerment, regardless of allergen 
severity, type of food allergy, or comorbidities [16]. 
Another study found that mothers reported significantly 
more negative impact than fathers regarding meal 
preparation, family social activities, stress, and free time, 
and significantly greater involvement in allergy-related 
care. However, fathers who reported more frequent 
medical appointment attendance perceived meal 
preparation as being significantly more impacted by food 
allergies than fathers who were less involved, suggesting 
that differences in impact may be related to the level of 
involvement in day-to-day activities rather than gender 
[17]. In peanut allergy specifically, a study of families 
including a child with peanut allergy found that mothers 
reported worse HRQL and more stress and anxiety than 
did fathers [18].
As outlined above, much previous research on 
caregiver impact has been conducted in food allergy 
in general, with limited studies focused on peanut 
allergy specifically. One study in peanut allergy found 
that a subset of parents of a child with peanut allergy 
experienced high levels of parenting stress [19]. Parents 
of a child with peanut allergy have also expressed 
difficulties with their child’s transition to independence 
and their own subsequent loss of control [20], suggesting 
that the child’s age may influence HRQL burden for 
caregivers. As discussed previously, one study found that 
caregiver gender may also influence caregiver burden in 
peanut allergy [18]. No research has previously explored 
the impact of peanut allergy specifically on caregiver 
work or productivity, although one survey of caregivers 
of children with any food allergy found that a small 
proportion (9%) reported a work-related impact of 
their child’s food allergy, such as career restrictions, job 
change, or job loss [21].
Thus, given the limited research on caregiver burden 
in peanut allergy specifically, the objectives of this study 
were to (1) describe the psychosocial and productivity 
impact of caring for a child with peanut allergy, (2) 
explore the effect of caregiver and child gender on 
caregiver HRQL, and (3) examine which factors 
predict caregiver HRQL in peanut allergy. To explore 
these objectives, we report on results from a survey 
of caregivers of children with peanut allergy aged 4 to 
15 years in the UK.
Methods
Study design
This study used a cross-sectional online survey to explore 
burden in caregivers of children aged 4 to 15  years 
with peanut allergy in the UK. The study was reviewed 
and approved by the Freiburg Ethics Commission 
International (FECI) prior to participant recruitment 
(FECI code: 017/1938; date: 20 November 2017).
Participants
Participants were recruited through a specialist survey 
recruitment panel. Participants were eligible for the study 
if they were a parent or primary caregiver of a child (aged 
4–15  years) with a medically diagnosed peanut allergy, 
who had experienced at least one reaction to peanuts 
in their day-to-day life (not a food challenge). In order 
to ensure diversity in the severity of peanut allergy in 
the sample, a quota was set for a minimum of 80% of 
participants who perceived the severity of their child’s 
peanut allergy as moderate or severe, with a minimum 
of 25% in the moderate/severe population having needed 
to use an adrenaline autoinjector, and a minimum of 10% 
having experienced a life-threatening event.
Procedure and measures
Eligible participants were provided with information 
about the study purpose and procedures. Participants 
were asked to read the information provided, and if 
interested in participating, were asked to give their 
consent online prior to completing the online survey. 
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Participants received nominal reimbursement for 
participating in the study.
The survey consisted of sociodemographic questions 
about the caregiver and their child and clinical 
questions about the child’s peanut allergy. The clinical 
questions included the caregivers’ perception of the 
severity of their child’s peanut allergy (mild, moderate, 
or severe), caregivers’ confidence in managing their 
child’s reactions to peanut allergy (“not at all confident” 
to “very confident”), the number of reactions to peanut 
their child experienced in the last 12 months and in the 
child’s lifetime, the type of treatment received in the last 
12 months and in their lifetime, and whether their child 
experienced a life-threatening reaction to peanut in the 
last 12  months and in their lifetime. Participants were 
also asked about the impact on their productivity due to 
their child’s peanut allergy, including the number of days 
they were absent from work in the last 12  months, the 
number of days their productivity was impacted in the 
past 12 months, and whether their career was impacted. 
The survey also included validated measures of caregiver 
HRQL (EQ-5D-5L, Food Allergy Quality of Life–Parental 
Burden [FAQL-PB]) and caregiver anxiety and depression 
(Hospital Anxiety and Depression Scale [HADS]) and a 
measure of caregiver food allergy-related expectation of 
outcome (Food Allergy Independent Measure-Parent 
Form [FAIM-PF]).
The EQ-5D-5L [22] is a generic, preference-based 
health status measure. Participants report their current 
health on five dimensions (mobility, self-care, pain and 
discomfort, usual activities, and anxiety and depression) 
with five response options for each dimension, from 
“no problems” to “extreme problems.” Responses are 
converted into a single index value that can be used in 
cost-effectiveness analyses, where a score of 1 represents 
“full health” and a score of 0 represents “dead.” The 
instrument was scored using the van Hout et  al. [23] 
mapping algorithm, which maps to the UK value set [24]. 
Participants also rate their current health on a 0 to 100 
visual analogue scale (VAS).
The FAQL-PB [25] was developed to assess burden for 
parents with food-allergic children. The FAQL-PB scale is 
a self-administered 17-item questionnaire. Each item is 
presented on a 7-point Likert scale ranging from 1 (not 
troubled) to 7 (extremely troubled). Items are summed to 
provide a total continuous score; higher scores indicate 
greater parental burden. The instrument can also be 
scored as two domains: limitations on life and emotional 
distress [26]. Validated for use in a UK sample, the scale 
has been found to have excellent reliability and validity 
with a Cronbach’s alpha of 0.952 for the overall scale, 
0.952 for the limitations on life subscale, and 0.860 for 
the emotional distress subscale [26].
The HADS [27] is a 14-item measure of anxiety 
and depression used in both hospital and community 
settings. The questionnaire gives clinically meaningful 
results as a psychological screening tool and can help in 
assessing the symptom severity and clinical “caseness” 
of anxiety disorders and depression in patients with 
illness and in the general population. The HADS provides 
separate scores for anxiety and depression, ranging 
in each from 0 to 21, with 0–7 indicating “normal” or 
no anxiety or depression, 8–10 indicating mild, 11–14 
indicating moderate, and 15–21 indicating severe anxiety 
or depression; scores of ≥ 11 indicate probable “caseness” 
[27]. Population norms related to the proportion of 
people reporting probable clinical caseness in the UK 
(based on adults aged 25 to 65 years) have been estimated 
at 12.5% (males) and 19% (females), with an average 
for males and females of 15.8% for anxiety and 6.9% for 
depression [28]. The HADS has been validated many 
times in different populations, with internal consistency 
for the anxiety scale ranging from α = 0.68–0.93 (mean: 
0.83) and the depression scale ranging from α = 0.67–
0.90 (mean: 0.82) [29].
The FAIM-PF [30] consists of four items related to the 
parent’s perception of their child’s likelihood of allergic 
reaction events (accidentally ingesting the food to which 
they are allergic, having a severe reaction, dying from 
their food allergy, effectively treating themselves when 
needed). Each item is answered on a 7-point scale, with 
FAIM scores ranging from 1 (extremely unlikely) to 7 
(extremely likely).
Analysis
Demographic and clinical characteristics were analysed 
using descriptive statistics. The FAQL-PB and HADS 
were scored according to their published scoring 
instructions [25–27]. In line with recommendations of 
the National Institute for Health and Care Excellence, 
EQ-5D-5L data were scored using the van Hout et  al. 
[23] mapping function. Pearson’s, point biserial, and 
Spearman’s correlations (where data were not normally 
distributed) were conducted as appropriate to explore 
relationships between variables. Correlations were 
interpreted in line with Cohen’s guidelines: small: 0.10 
to < 0.30; moderate: 0.30 to < 0.50; large: ≥ 0.50 [31]. 
To explore the impact of caregiver and child gender on 
caregiver burden, two-way ANOVA (analysis of variance) 
and Chi square tests were conducted. Chi square 
tests were also conducted to explore the association 
between peanut allergy severity and caregiver career 
impact. To further explore which outcomes significantly 
predicted caregiver impact, multivariate ordinary least 
squares regression models were conducted. To assess 
whether EQ-5D and HADS scores were significantly 
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different from population norms, one-sample t-tests 
and one-sample tests of proportion were conducted as 
appropriate. Results of statistical tests were considered 
statistically significant if p values were below 0.05. All 
analyses were conducted using Stata version 16.0.
Results
The survey information and link were sent to 1330 panel 
members; 100 caregivers were eligible and completed 
the survey. Demographics and clinical characteristics of 
the caregivers and their children are shown in Table  1. 
The caregivers had a mean age of 40 years (SD 7.6; range 
21–65  years), and their children with peanut allergy 
had a mean age of 10  years (SD 3.4; range 4–15  years). 
The sample contained male (45%) and female (55%) 
caregivers. Parents and children had high proportions 
of allergic rhinitis (parents 22%, children 36%), asthma 
(parents 20%, children 34%), and skin disorders (parents 
17%, children 26%).
Impact of caregiving
Summaries of the impact of being a caregiver to a child 
with peanut allergy relative to levels of anxiety and 
depression as well as generic and food-allergy-specific 
Table 1 Caregiver and child demographic and clinical characteristics
AAI adrenaline autoinjector, n sample size, SD standard deviation
Characteristic Caregivers (N = 100) Children (N = 100)
Age, years Mean (SD) 39.49 (7.59) 9.82 (3.42)
Min–max 21–65 4–15
Female N 55 42
Ethnicity, n White 85 86
Black 4 0
Asian 10 9
Mixed race 1 5
Main occupation, n Employed outside the home 89 –
Looking after family and/or home 6 –
Other 5 –
Comorbidities, n Allergic rhinitis 22 36
Asthma 20 34
Eating disorder 7 6
Skin disorder 17 26
Stress 13 5
Other 16 11
None 37 28
Caregiver, food allergy, n Peanut allergy 10 –
Other food allergy 11 –
Child, food allergies other than peanut, n (%) No – 76 (76.0)
Yes – 24 (24.0)
  If “Yes,” food allergy, n (%) Celery – 2 (8.3)
Cow milk/dairy products – 6 (25.0)
Egg – 11 (45.8)
Fish/shellfish – 1 (4.2)
Soya beans/other legumes – 1 (4.2)
Other nuts – 11 (45.8)
Other – 5 (21.0)
Prescribed an AAI, n Yes 71
Experienced life-threatening event (lifetime n) Yes 34
Number of reactions (lifetime) Mean (SD) 11.98 (28.2)
Peanut allergy severity as reported by caregiver, n Mild – 13
Moderate – 66
Severe – 21
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measures of HRQL are presented in Table  2 and Fig.  1. 
All health-outcome measures were highly significantly 
correlated with each other (r’s = 0.42–0.65, p’s < 0.001), 
indicating medium to large effect sizes [31]. Table  2 
shows that caregivers’ mean anxiety levels overall and 
for each subgroup (peanut allergy severity, caregiver 
gender) are all above the normal range (HADS normal 
range: scores of 0–7). The mean scores are significantly 
higher than the population norm [28] for the overall 
sample (t = 4.00, p < 0.001), males (t = 3.07, p < 0.001), 
females (t = 2.44, p < 0.05), and for those who rate their 
child’s peanut allergy as moderate (t = 3.44, p < 0.001) or 
Table 2 Caregiver-reported measures of burden by gender and child peanut allergy severity
FAQL-PB Food Allergy Quality of Life-Parental Burden, HADS Hospital Anxiety and Depression Scale, PA peanut allergy, SD standard deviation, UK United Kingdom, VAS, 
visual analogue scale
a  EQ-5D: Utility index scores range from 0 (dead) to 1 (full health); VAS ranges from 0 to 100. UK population norm: 18–64-year-olds: overall: utility: 0.885, VAS: 84.72; 
males: mean utility = 0.880, mean VAS = 85.22; females: mean utility = 0.888, mean VAS = 84.38 [32]
b  Scores range from 0 to 21: 0–7 = “normal” or no anxiety or depression, 8–10 = mild, 11–14 = moderate, 15–21 = severe anxiety or depression. Scores of ≥ 11 indicate 
probable “caseness.” UK population norms: anxiety = 6.15, depression = 3.98 [28]
*Significantly different from UK population norms (p < 0.05)
**Significantly different from UK population norms (p < 0.001)
N EQ-5 Da HADSb FAQL-PB
Utility VAS Anxiety Depression Total score Emotional distress Life limitations
Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD)
Total sample 100 0.873 (0.209) 79.96 (17.70)* 8.09 (4.85)** 4.93 (4.20)* 2.98 (1.56) 2.96 (1.63) 3.02 (1.52)
Caregiver gender
 Male 45 0.867 (0.243) 79.00 (17.09)* 7.73 (4.86)** 4.89 (4.02) 3.00 (1.50) 2.98 (1.58) 3.03 (1.44)
 Female 55 0.879 (0.179) 80.75 (18.30) 8.38 (4.87)* 4.96 (4.38) 2.97 (1.61) 2.95 (1.69) 3.01 (1.59)
Child PA severity
 Mild 13 0.913 (0.204) 83.08 (11.43) 5.92 (4.23) 4.31 (3.99) 2.48 (1.37) 2.50 (1.48) 2.45 (1.21)
 Moderate 66 0.888 (0.185) 80.18 (17.41)* 8.26 (4.98)** 5.23 (4.44)* 2.93 (1.58) 2.92 (1.65) 2.95 (1.54)
 Severe 21 0.803 (0.273) 77.33 (21.77) 8.91 (4.63)* 4.38 (3.57) 3.45 (1.54) 3.40 (1.64) 3.56 (1.49)
Fig. 1 Proportion of HADS Anxiety categories (normal, mild, moderate/severe) by gender and child’s peanut allergy severity. HADS Hospital Anxiety 
and Depression Scale, PA peanut allergy, UK United Kingdom
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severe (t = 2.73, p < 0.05). Caregivers’ depression mean 
scores for each subgroup all fall within the normal range 
(HADS score of 0–7) but are significantly higher than UK 
population norms overall (t = 2.26, p < 0.05). Similarly, 
caregiver rates of probable clinical anxiety (moderate/
severe HADS scores of > 10) are approximately double 
the UK population norms (UK norms: mean = 15.75%, 
males = 12.5%, females = 19%) and significantly higher 
for the total sample (31%; z = 4.2, p < 0.001), males (26%, 
z = 2.9, p < 0.01), females (35%, z = 2.9, p < 0.001), and 
those reporting a child with moderate peanut allergy 
(33%, z = 3.9, p < 0.001) or severe peanut allergy (33%, 
z = 2.2, p < 0.05) (Fig. 1).
Overall, generic HRQL, as measured by the EQ-5D 
utility index, was similar to UK population norms, 
although VAS scores overall were significantly lower than 
population norms (UK norm for those aged 18–64 years 
mean utility overall = 0.885, mean VAS = 84.72 
[32]; VAS compared to population norm: t = − 2.69, 
p < 0.05). However, in the subgroup that perceived their 
children to have severe peanut allergy, generic HRQL 
was lower than norms using both utility index (mean 
0.803, population norm 0.885) and VAS (mean 77.22, 
population norm 84.72), yet these differences were not 
significant (p > 0.05) considering the small sample size of 
the “severe” subgroup. Disutility associated with having a 
child with increased peanut allergy severity ranged from 
0.025 (mild utility = 0.913 vs moderate utility = 0.888) to 
0.11 (mild utility = 0.913 vs severe utility = 0.803), with 
a mean disutility of 0.068 (see Table  2 for mean utility 
values). The utility decrement was largely driven by the 
EQ-5D anxiety and depression domain: 44% of caregivers 
reported being at least slightly anxious or depressed, 
compared with those reporting at least slight problems 
with self-care (7%), mobility (9%), usual activities (17%), 
and pain or discomfort (19%).
The FAQL-PB food-allergy-specific quality-of-life data 
suggest minimal (mean scores of 2–3) to moderate (mean 
scores of 3–4) levels of trouble/burden. The results show 
a statistically significant increase in caregiver burden 
among those with children reported to have severe 
versus mild peanut allergy in the FAQL-PB limitations 
on life domain (B = 6.64, 95% CI 0.36–12.92, p < 0.05). 
To illustrate this burden with more concrete descriptive 
examples of the impact, Fig.  2 shows the proportion of 
caregivers who reported being “very” or “extremely” 
burdened with respect to specific activities and concerns 
(preparing meals, social limitations, others’ attitudes, 
fear of reactions) according to their child’s peanut allergy 
severity.
Table  3 presents absenteeism, productivity, and 
career impact results. The overall mean number of days 
absent in the last 12 months and productivity impacted 
among caregivers currently in paid employment due to 
Fig. 2 Caregivers who reported being very/extremely impacted on FAQL-PB items, by child’s peanut allergy severity group. FAQL-PB Food Allergy 
Quality of Life–Parental Burden
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their child’s allergy were M = 1.6 (SD: 2.2) and M = 1.9 
(SD: 3.6), respectively. Absenteeism and productivity 
impacts increased with severity of child’s allergy, but 
not significantly (p > 0.05); however, career impact was 
significantly associated with increased severity (χ2 = 9.19, 
p = 0.01), with 43% of caregivers of children with severe 
peanut allergy reporting some career impact (e.g., having 
to change job or stop work or having restricted career 
choices).
Relationship between gender and caregivers’ burden
Neither caregiver gender nor child gender were 
significantly correlated with any of the measures of 
caregiver burden (all r’s < 0.2, all p’s > 0.05). ANOVAs and 
Chi square tests showed that caregiver and child gender 
did not have any significant main or interaction effects on 
any of the measures of caregiver burden (all p’s > 0.05).
Factors impacting caregiver burden
The significant correlations between measures of burden 
and potential predictors of burden are detailed in Table 4. 
All other potential predictors (adrenaline autoinjector 
use, caregiver and child gender, child age) were not 
significantly associated with outcome assessments.
Multivariate regression models for each outcome 
assessment are presented in Table  5. As the number 
of reactions in the past 12  months and in the child’s 
lifetime are not independent of each other, these were 
run in separate models. Also, given the high correlations 
between FAIM items and total FAIM score, only the 
Table 3 Caregiver-reported absenteeism, productivity, and career impact by gender and child peanut allergy severity
N sample size, PA peanut allergy
Currently employed Total Sample
N Days absent from work (last 
12 months)
Days productivity impacted (last 
12 months)
N Negative career 
impact (overall): 
Yes
Mean (SD) Mean (SD) %
Total 91 1.60 (2.20) 1.87 (3.64) 100 22
Caregivers by gender
 Male 45 1.87 (2.36) 1.71 (2.73) 45 23
 Female 46 1.35 (2.01) 2.02 (4.38) 55 22
Severity of child’s PA
 Mild 12 1.08 (2.47) 0.50 (1.24) 13 0
 Moderate 61 1.67 (2.12) 1.84 (3.84) 66 20
 Severe 18 1.72 (2.35) 2.89 (3.83) 21 43
Table 4 Correlations between caregiver burden outcomes and potential predictors of burden
FAIM Food Allergy Independent Measure, FAQL-PB Food Allergy Quality of Life–Parental Burden, HADS Hospital Anxiety and Depression Scale, VAS visual analogue 
scale
* p < 0.05, ** p < 0.01, *** p < 0.001
EQ-5D FAQL-PB HADS
Utility VAS Total Emotional Limitations Anxiety Depression
Proxy-reported severity − 0.201* − 0.035 0.187 0.167 0.208* 0.168 0.004
Confidence 0.004 0.199* − 0.229* − 0.203* − 0.266** − 0.215* − 0.323**
Life threat, past 12 mo − 0.330*** − 0.248* 0.324** 0.327*** 0.295** 0.250* 0.156
Life threat, lifetime − 0.278** − 0.213* 0.302** 0.286** 0.312** 0.152 0.014
Reactions, past 12 mo − 0.262** − 0.354*** 0.385*** 0.383*** 0.380*** 0.226* 0.344***
Reactions, lifetime − 0.317** − 0.327*** 0.377*** 0.367*** 0.379*** 0.239* 0.235*
FAIM Total − 0.398*** − 0.344*** 0.602*** 0.588*** 0.587*** 0.400*** 0.379***
FAIM Ingest peanut − 0.349*** − 0.387*** 0.617*** 0.612*** 0.584*** 0.440*** 0.444***
FAIM Severe reaction − 0.263** − 0.220* 0.438*** 0.423*** 0.440*** 0.336** 0.258**
FAIM Dying − 0.418*** − 0.360*** 0.551*** 0.537*** 0.542*** 0.398*** 0.410***
FAIM Treatment 0.268** − 0.161 0.368*** 0.360*** 0.358*** 0.240* 0.131
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Table 5 Multiple regression models with caregiver burden outcome measures as dependent variables
B standardized beta coefficient, CI confidence interval, FAIM Food Allergy Independent Measure, FAQL-PB Food Allergy Quality of Life – Parental Burden, HADS Hospital 
Anxiety and Depression Scale, Ref reference category, SE standard error, VAS visual analogue scale
* p < 0.05, ** p < 0.01, *** p < 0.001
Outcome/predictors B SE 95% CI
Lower Upper
EQ-5D Utility
 FAIM Total − 0.011** 0.004 − 0.020 − 0.003
 Life-threat. in past 12 mo (Ref: No) Yes − 0.089 0.046 − 0.181 0.004
 Reactions in past 12 mo, n (Ref: None) 1 − 0.015 0.060 − 0.133 0.104
2 or more − 0.076 0.054 − 0.183 0.032
 Proxy-reported severity (Ref: Mild) Moderate − 0.017 0.058 − 0.132 0.097
Severe − 0.053 0.069 − 0.190 0.084
EQ-5D VAS
 FAIM total − 0.907** 0.341 − 1.583 − 0.230
 Confidence 3.978* 1.947 − 0.128 7.568
 Life-threat. in past 12 mo (Ref: No) Yes − 4.135 3.937 − 11.952 3.682
 Reactions in past 12 mo, n (Ref: None) 1 − 3.706 4.984 − 13.602 6.190
2 + − 9.394* 4.585 − 18.497 − 0.290
HADS anxiety
 FAIM total 0.336** 0.927 0.149 0.518
 Caregiver confidence − 1.287* 0.530 − 2.338 − 0.235
 Life-threat. in past 12 mo (Ref: No) Yes 1.377 1.071 − 0.750 3.504
 Reactions in past 12 mo, n (Ref: None) 1 0.822 1.356 − 1.871 3.515
2+ 1.044 1.248 − 1.433 3.521
HADS depression
 FAIM_Q1_sum 0.272** 0.076 0.121 0.424
 Caregiver confidence − 1.557** 0.436 − 2.423 − 0.691
 Life-threat. in past 12 mo (Ref: No) Yes − 0.134 0.882 − 1.886 1.617
 Reactions in past 12 mo, n (Ref: None) 1 1.988 1.117 − 0.229 4.206
2 + 2.750** 1.027 0.710 4.790
FAQL-PB total
 FAIM total 2.766*** 0.420 1.931 3.601
 Caregiver confidence − 7.321** 2.402 − 12.091 − 2.553
 Life-threat. in past 12 mo (Ref: No) Yes 8.871 6.150 − 3.340 21.081
 Reactions in past 12 mo, n (Ref: None) 1 8.871 6.150 − 3.340 21.081
2 + 12.228* 5.657 − 0.995 23.461
FAQL-PB life limitations
 FAIM total 0.897*** 0.150 0.599 1.196
 Caregiver confidence − 2.959** 0.830 − 4.606 − 1.311
 Life-threat. in past 12 mo (Ref: No) Yes 1.710 1.663 − 1.593 5.013
 Reactions in past 12 mo, n (Ref: None) 1 4.176 2.134 − 0.061 8.414
2 + 4.748* 1.946 0.883 8.612
 Proxy-reported severity (Ref: Mild) Moderate 2.789 2.063 − 1.308 6.886
Severe 4.157 2.468 − 0.745 9.059
FAQL-PB emotions
 FAIM Total 1.828*** 0.294 1.245 2.412
 Caregiver confidence − 4.427* 1.678 − 7.759 − 1.095
 Life-threat. in past 12 mo (Ref: No) Yes 5.067 3.394 − 1.672 11.806
 Reactions in past 12 mo, n (Ref: None) 1 5.239 4.296 − 3.292 13.769
2 + 7.672 3.952 − 0.175 15.520
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total score was included in the models. The regression 
models show that for all measures of caregiver burden, 
the caregivers’ increased expectation of negative 
outcomes as measured by the FAIM (e.g., perception 
of risk of dying, having a severe reaction, or accidental 
ingestion of allergen) significantly increased burden. 
For all except EQ-5D utility, caregiver confidence also 
significantly predicted burden, with higher confidence 
associated with lower burden. The number of reactions 
in the past 12  months was the only other relatively 
consistent predictor of burden (EQ-5D VAS, FAQL-PB 
total and limitation domain, and HADS depression), 
with significantly increased burden associated with 2 or 
more reactions in the past 12  months. All models were 
repeated with “lifetime” reactions or life-threatening 
events, but these were only significant predictors for (1) 
FAQL-PB limitations domain, where having had a life-
threatening event was associated with a 3-point increase 
in score (B = 2.97, p < 0.05) and (2) EQ-5D VAS, where 
having had ≥ 6 reactions in one’s lifetime versus zero 
reactions was associated with a 9-point decrease on the 
VAS (B = − 8.90, p < 0.05). The significant association 
between a child’s proxy-reported severity and FAQL-PB 
total score, and between severity and EQ-5D utility, 
were no longer significant when other predictors were 
considered.
Discussion
This study helps provide a better understanding of the 
impact, and its driving factors, associated with being a 
caregiver to a child with peanut allergy in the UK. The 
study highlighted the psychological burden experienced 
by caregivers of children with peanut allergy, revealing 
levels of anxiety and depression significantly higher 
than UK population norms for males (anxiety and 
depression) and females (anxiety only) and rates of 
probable clinical anxiety significantly higher than the 
UK population. There was a trend toward poorer health 
utility values among caregivers who perceived their 
child to have severe peanut allergy relative to the general 
population, although differences were not statistically 
significant, likely due to the small sample size of the 
“severe” group. These peanut-allergy-specific caregiver 
utility values are the first to be published and indicate 
that the HRQL burden for caregivers of children with 
peanut allergy is largely driven by the levels of anxiety 
and depression experienced. Furthermore, caregivers 
of children with severe peanut allergy also reported 
significant impacts on their careers and limitations to 
their HRQL. Notably, caregiver gender did not impact 
burden, as the study indicated that male and female 
caregivers are equally anxious and suffer the same level 
of negative career, productivity, and HRQL impact due 
to their child’s peanut allergy.
This study found that caregivers’ expectations of 
outcome, specifically their perception of their child’s risk 
of allergen exposure, having a severe reaction, dying, 
or being able to effectively treat themselves (measured 
using the FAIM) independently predicted all measures 
of caregiver burden. Caregiver confidence was also an 
independent predictor of burden (for all measures except 
utility). Objective measures of severity such as life-
threatening events and number of reactions were also 
significantly associated with burden; however, these did 
not retain significance in multivariate models, suggesting 
that these events are captured within the measures of 
caregivers’ expectations and levels of confidence.
The results of this study support previous research 
showing a negative impact of peanut allergy on caregiver 
HRQL [18]. In contrast to previous research showing a 
gender difference in caregiver burden in peanut allergy 
and food allergy, the current study suggests there is no 
difference, as both male and female caregivers reported 
a negative impact. Similarly, comparable levels of career 
impact were reported by male and female caregivers, 
suggesting equal involvement in peanut-allergy-related 
care. This may support previous findings that any gender 
differences may be related to the level of involvement 
rather than gender [17]. In addition, previous research 
showing differences in responses based on the gender 
of caregivers of children with peanut allergy [18] used 
a smaller sample size recruited from a specialist allergy 
center and was published 10  years ago; the more 
current data reported here may reflect increased shared 
responsibility between parents.
This study found that caregiver expectation of outcome 
measured using FAIM was the key driver of caregiver 
burden in peanut allergy; this is in contrast to previous 
research that found the FAIM was not a significant 
predictor of caregiver psychosocial impact [33]. 
However, caregiver self-efficacy (confidence) has been 
shown to predict the psychosocial impact of food allergy 
[14], which is consistent with the current study’s finding 
that caregiver confidence predicted several measures of 
caregiver burden. A number of studies have shown that 
food allergy reaction history impacts caregiver burden [8, 
10, 11], although these studies did not include FAIM in 
the same regression model. In the current study, reaction 
history in terms of the number of reactions and having 
experienced a life-threatening event showed some impact 
on caregiver burden but was not the main driver when 
parental expectation of outcome (measured by FAIM) 
was also included.
Some limitations should be considered when 
interpreting the results of this study. The research was 
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conducted in the UK only; therefore, the results may 
not be generalizable to caregivers in other countries. 
In addition, the sample size of 100 is relatively small 
and so some of the analyses may be underpowered, 
such as the differences between the severe peanut 
allergy population versus general population norms. 
Another limitation is that the severity of peanut allergy 
can be difficult to objectively measure, given that food 
allergic reactions are unpredictable, and severity is 
not determined by test results or history of reaction; 
clinical severity as reported by parents should be 
considered a subjective measure. Thus, it is important 
to interpret results of analyses exploring associations 
between peanut allergy severity and caregiver impact as 
reflecting caregiver perception of severity, rather than 
clinical severity itself. Future research could expand 
on this study by increasing the sample size, exploring 
parent and child dyads, and exploring the burden 
experienced by caregivers of children with peanut 
allergy in other countries.
Conclusions
This study highlights the burden experienced by 
caregivers of children with peanut allergy in the UK, 
particularly the high levels of anxiety reported by both 
male and female caregivers. In addition, caregivers of 
children with severe peanut allergy report significant 
impacts on their careers and limitations in their HRQL. 
The study also found that caregiver expectation of 
outcome, confidence, and several objective measures 
of severity were significantly associated with caregiver 
burden.
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